BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29393513)

  • 1. Do Women Find the Progesterone Vaginal Ring Acceptable? Findings from Kenya, Nigeria, and Senegal.
    RamaRao S; Obare F; Ishaku S; Mané B; Clark H; Liambila W; Unumeri G; Birungi H; Diop N; Rajamani D; Townsend J
    Stud Fam Plann; 2018 Mar; 49(1):71-86. PubMed ID: 29393513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing the Progesterone Vaginal Ring (PVR) as a New Option for Postpartum Family Planning in Sub-Saharan Africa: Insights from Engagements with Stakeholders.
    Ishaku SM; Diop N; Mané B; Liambila W; RamaRao S; Clark H; Birungi H; Unumeri G; Obare F
    Afr J Reprod Health; 2018 Jun; 22(2):68-75. PubMed ID: 30052335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review.
    Carr SL; Gaffield ME; Dragoman MV; Phillips S
    Contraception; 2016 Sep; 94(3):253-61. PubMed ID: 25869631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
    Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
    Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone vaginal ring: introducing a contraceptive to meet the needs of breastfeeding women.
    RamaRao S; Clark H; Merkatz R; Sussman H; Sitruk-Ware R
    Contraception; 2013 Nov; 88(5):591-8. PubMed ID: 23769015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing contraceptive choice for postpartum women in sub-Saharan Africa with the progesterone vaginal ring: a review of the evidence.
    RamaRao S; Ishaku S; Liambila W; Mane B
    Open Access J Contracept; 2015; 6():117-123. PubMed ID: 29386929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring.
    Roumen FJ; Dieben TO
    Contraception; 1999 Jan; 59(1):59-62. PubMed ID: 10342086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-use ring weight and residual drug content as potential objective measures of user adherence to a contraceptive progesterone vaginal ring.
    Murphy DJ; McCoy CF; Plagianos M; RamaRao S; Merkatz R; Clark H; Boyd P; Variano B; Malcolm RK
    Contraception; 2019 Sep; 100(3):241-246. PubMed ID: 31247194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial.
    Massai R; Quinteros E; Reyes MV; Caviedes R; Zepeda A; Montero JC; Croxatto HB
    Contraception; 2005 Nov; 72(5):352-7. PubMed ID: 16246661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Husbands' concerns and experiences with the progesterone vaginal ring in three sub-Saharan African countries: a mixed methods study.
    Obare F; Mbow F; RamaRao S; Hazra A
    Sex Reprod Health Matters; 2022; 29(3):2104680. PubMed ID: 35975870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone vaginal ring for contraceptive use during lactation.
    Nath A; Sitruk-Ware R
    Contraception; 2010 Nov; 82(5):428-34. PubMed ID: 20933116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidal contraceptive vaginal rings.
    Sarkar NN
    Int J Clin Pract; 2003 Jun; 57(5):392-5. PubMed ID: 12846344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing and Using the Progesterone Vaginal Ring: Women's Lived Experiences in Three African Cities.
    Undie CC; RamaRao S; Mbow FB
    Patient Prefer Adherence; 2020; 14():1761-1770. PubMed ID: 33061318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of research and development of vaginal contraceptive rings as a fertility control method in the female.
    Roy S; Mishell Dr
    Res Front Fertil Regul; 1983 May; 2(4):1-10. PubMed ID: 12227323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of contraceptive vaginal rings].
    Elstein M; Jackson R; Hickling D; Assendorp R
    Contracept Fertil Sex (Paris); 1992 Jan; 20(1):15-9. PubMed ID: 12343624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hormonal ring. A new contraceptive gains acceptance.
    Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
    IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal rings for menopausal symptom relief.
    Ballagh SA
    Drugs Aging; 2004; 21(12):757-66. PubMed ID: 15382956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive rings provide simple protection.
    Popul Briefs; 1997; 3(2):4. PubMed ID: 12292642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.